Correction

Doctors announce first NIH-funded AIDS treatment research in Africa

Published in Medical Letter on the CDC and FDA, December 28th, 2003

According to an emailed letter from Brady Dewar on behalf of Gilead Sciences:

[helv]The article [Doctors announce first NIH-funded AIDS treatment research in Africa, NewsRx November 30, 2003] refers to the antiretroviral drug emtricitabine as having the trade-name Coviracil and as being marketed by Triangle Pharmaceuticals. In fact, emtricitabine, which was approved for marketing by the FDA in July, is sold as Emtriva by Gilead Sciences. Triangle Pharmaceuticals, and with it emtricitabine, was acquired by Gilead Sciences in January 2003.[helv]

This article was prepared by Medical Letter on the CDC & FDA editors from staff and other reports. ...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2003-12-28)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry